Clinical trial
EndoForce Post Approval Study
NCT07146854 is registered in ClinicalTrials.gov with Phraxis, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EndoForce Post Approval Study
- Lead sponsor
- Phraxis, Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 13, 2026
- Completion date
- December 31, 2029
- Enrollment
- 150 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease (esrd)